Chand Sishta

I worked with Jill while at BMS in the Mature Products area, and much of the continued success in ensuring that the portfolio remains vital was possible because of Jill’s leadership. Her technical capabilities in business development or portfolio management or people development are unquestionably world-class. Now, Jill has started a new career in her own company, and the leadership qualities that Jill displayed at BMS will follow into a great new direction. Anyone who has the good fortune to seek her guidance in pharmaceutical lifecycle management will be met with a passionate champion of how to think about product development, asset growth and the sometimes necessary divestiture or discontinuation of a product. Whether you are in a start up with your first product or a senior executive in a well-established organization, Jill will help you make informed decisions in support of your asset’s lifecycle.